Numerical chromosomal changes in metastatic prostate cancer following anti-androgen therapy: Fluorescence in situ hybridization analysis of 5 Japanese cases

Cancer Genetics and Cytogenetics

Volumn 120, Issue 2, 2000, Pages 148-154

  Karashima, Takashi ^a   Taguchi, Takahiro ^a   Yoshikawa, Chiaki ^a   Kamada, Masayuki ^a   Kasahara, Kotaro ^a   Yuri, Kazunari ^a   Shuin, Taro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER GRADING; CANCER STAGING; CENTROMERE; CHROMOSOME 10; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; MALE; METASTASIS; NEEDLE BIOPSY; PATHOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; RELAPSE; SAMPLE; Y CHROMOSOME;

AGED; ANDROGEN ANTAGONISTS; ANEUPLOIDY; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 8; FATAL OUTCOME; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; JAPAN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; Y CHROMOSOME;

EID: 0034661306     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00208-9     Document Type: Article

References (24)

1. Kuroishi T (1995): Epidemiology of prostate cancer. Klinika 25:43-48.
2. Pinkel D, Straume T, Gray JW (1986): Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 83:2934-2938.
3. Van Dekken H, Pizzolo JG, Reuter VE, Melamed MR (1990): Cytogenetic analysis of human solid tumors by in situ hybridization with a set of 12 chromosome-specific DNA probes. Cytogenet Cell Genet 54:103-107.
4. Taguchi T, Zhou J-Y, Feder M, Litwin S, Kein-Szanto AJP, Testa JR (1996): Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosome specific repetitive DNA probes. Cancer Genet Cytogenet 89:120-125.
5. Alers JC, Krijtenburg PJ, Vissers KJ, Bosman FT, van der Kwast TH, van Dekke H (1995): Interphase cytogenetics of prostatic adenocarcinomas and precursor lesions. Genes Chromosom Cancer 12:241-250.
6. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, Jenkins RB (1995): Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinomas detected by fluorescence in situ hybridization. Cancer Res 55: 5408-5414.
7. Brown JA, Alcaraz A, Takahashi S, Persons DL, Leiber MM, Jenkins RB (1994): Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma. J Urol 152:1157-1162.
8. Visakorpi T, Hyttinen E, Kallioniemi A, Isola J, Kallioniemi O-P (1994): Sensitive detection chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am J Pathol 145:624-630.
9. Wang R-Y, Troncoso P, Palmer JL, EI-Naggar AK, Liang C (1996): Trisomy 7 dual-color fluorescence in situ hybridization: a potential biological marker for prostate cancer progression. Clin Cancer Res 2:1553-1558.
10. Matsuura H, Shiraishi T, Yatani R, Kawamura J (1996): Interphase cytogenetics of prostate cancer: fluorescence in situ hybridization (FISH) analysis of Japanese cases. Br J Cancer 74:1699-1704.
11. Takahashi S, Alcaraz A, Brown JA, Borell JT, Herath FJ, Bergstralh JE, Lieber MM, Jenkins BR (1996): Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prostatic markers for pathological stage C (pT3N0M0) prostate carcinoma. Clin Cancer Res 2:137-145.
12. Takahashi S, Qian J, Brown J, Alcaraz A, David G, Bostwick DG, Jenkins BR (1994): Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res 54:3574-3579.
13. Matsuyama H, Pan Y, Skoog L, Tribukait B, Naito K, Ekman P, Lichter P, Bergerheim Ulf SR (1994): Detection mapping of chromosome 8q in prostate cancer by fluorescence in situ hybridization. Oncogene 9:3071-3076.
14. Gleason DF (1977): Histologic grading and clinical staging of prostate carcinoma. In: Urologic Pathology: The Prostate. M Tannenbaum, ed. Lea and Febiger, Philadelphia, pp. 171-197.
15. Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz M, Pavonemacaluso M (1992): TNM classification of prostate cancer. Prostate 4(suppl):129-138.
16. Soloway MS (1988): Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 61:195-202.
17. Japanese Urological Association and the Japanese Society of Pathology (1992): General Rule for Clinical and Pathological Studies on Prostatic Cancer, 2nd Ed. Kanehara, Tokyo.
18. Jenkins RB, Qian J, Lieber MM, Bostwick DG (1997): Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 57:524-531.
19. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh E, Larson-Keller J, Lieber M, Jenkins RB (1994): Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54:3998-4002.
20. Bandyk MG, Zhao L, Toroncoso P, Pisters LL, Paimer JL, Eschenbach AC, Chung LWK, Liang LC (1994): Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosom Cancer 9:19-27.
21. Visakorpi T, Kallioniemi S, Syvanen A, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi O (1995): Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
22. Nupponen NN, Kakkola L, Koivisto P, Visakorpi T (1998): Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am J Pathol 153:141-148.
23. Nupponen NN, Hyytinen ER, Kallioniemi AH, Visakorpi T (1998): Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization. Cancer Genet Cytogenet 101:53-57.
24. Williams BJ, Jones E, Koziowski JM, Vessella R, Brothman AR (1997): Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts. Genes Chromosom Cancer 18:299-304.